Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acina r morphogenesis through O-glycosylation of fibronectin

Neoplasia

Volumn 13, Issue 4, 2011, Pages 320-326

  Park, Jae Hyun ^a   Katagiri, Toyomasa ^b   Chung, Suyoun ^a   Kijima, Kyoko ^a   Nakamura, Yusuke ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLYCOSYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 6; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYME CELL; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN STABILITY;

EID: 79953708277     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.101440     Document Type: Article

References (26)

1. Burchell JM, Mungul A, and Taylor-Papadimitriou J (2001). O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 6, 355-364.
2. Dube DH and Bertozzi CR (2005). Glycans in cancer and inflammation- potential for therapeutics and diagnostics. Nat Rev Drug Discov 4, 477-488.
3. Brockhausen I (2006). Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7, 599-604.
4. Park JH, Nishidate T, Kijima K, Ohashi T, Takegawa K, Fujikane T, Hirata K, Nakamura Y, and KatagiriT(2010). Critical roles ofmucin 1 glycosylation by transactivated polypeptideN-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res 70, 2759-2769.
5. Freire T, Berois N, Sonora C, Varangot M, Barrios E, and Osinaga E (2006). UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow- disseminated breast cancer cells. Int J Cancer 119, 1383-1388.
6. Debnath J, Muthuswamy SK, and Brugge JS (2003). Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
7. Debnath J and Brugge JS (2005). Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev Cancer 5, 675-688.
8. Ju X, Katiyar S,Wang C, Liu M, Jiao X, Li S, Zhou J, Turner J, Lisanti MP, Russell RG, et al. (2007). Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci USA 104, 7438-7443.
9. HanHJ, Russo J, Kohwi Y, and Kohwi-Shigematsu T (2008). SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452, 187-193.
10. Abramoff MD, Magelhaes PJ, and Ram SJ (2004). Image processing with ImageJ. Biophotonics Int 11, 36-42.
11. Kinsey R, Williamson MR, Chaudhry S,Mellody KT, McGovern A, Takahashi S, Shuttleworth CA, and Kielty CM (2008). Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J Cell Sci 121, 2696-2704.
12. Park JH, Lin ML, Nishidate T, Nakamura Y, and Katagiri T (2006). PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res 66, 9186-9195.
13. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, Tsunoda T, Kamatani N, Kubo M, Nakamura Y, et al. (2009). Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137, 1768-1775.
14. Lee JM, Dedhar S, Kalluri R, and Thompson EW (2006). The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172, 973-981.
15. Maeda M, Johnson KR, and Wheelock MJ (2005). Cadherin switching: essential for behavioral but not morphological changes during an epithelium-tomesenchyme transition. J Cell Sci 118, 873-887.
16. Debnath J,Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, and Brugge JS (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40.
17. Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, and Clausen H (1999). Cloning and characterization of a close homologue of human UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 274, 25362-25370.
18. Williams CM, Engler AJ, Slone RD, Galante LL, and Schwarzbauer JE (2008). Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 68, 3185-3192.
19. Altschuler Y, Kinlough CL, Poland PA, Bruns JB, Apodaca G, Weisz OA, and Hughey RP (2000). Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. Mol Biol Cell 11, 819-831.
20. Hu P, Berkowitz P, Madden VJ, and Rubenstein DS (2006). Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J Biol Chem 281, 12786-12791.
21. Jensen PH, Kolarich D, and Packer NH (2010). Mucin-type O-glycosylation- putting the pieces together. FEBS J 277, 81-94.
22. Ten Hagen KG, Fritz TA, and Tabak LA (2003). All in the family: the UDPGalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13, 1R-16R.
23. Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF, Totpal K, et al. (2007). Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 13, 1070-1077.
24. Ichikawa S, Sorenson AH, Austin AM, Mackenzie DS, Fritz TA, Moh A, Hui SL, and Econs MJ (2009). Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 150, 2543-2550.
25. Agard NJ and Bertozzi CR (2009). Chemical approaches to perturb, profile, and perceive glycans. Acc Chem Res 42, 788-797.
26. Sottile J and Chandler J (2005). Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell 16, 757-768.